--- a
+++ b/clusters/9knumclustersv2/clust_1367.txt
@@ -0,0 +1,12 @@
+Provision of signed and dated written informed consent prior to any study-specific procedures, sampling, and analyses. If a patient declines to participate in any voluntary exploratory research and/or genetic component of the study, there will be no penalty or loss of benefit to the patient and he/she will not be excluded from other aspects of the study.
+Patient must consent to the study and provide a signed and dated, written informed consent document prior to any study-specific procedures, sampling, or analyses.
+For inclusion in the optional PGx research, patients must provide informed consent for the genetic sampling and analyses.
+Provision of signed and dated, written informed consent prior to any study specific procedures, sampling and analyses; including access to all archival tumour tissue (diagnostic and/or most recent samples)
+Provide informed consent for genetic sampling and analyses
+Provision of signed and dated, written Informed Consent Form (ICF) prior to any trial-specific procedures, sampling, or analyses. If a patient declines to participate in the voluntary pharmacogenetics component of the trial, he/she will not be excluded from other aspects of the trial.
+Provision of signed and dated, written informed consent prior to any study-specific procedures, sampling and analyses.
+Ability to understand and the willingness to sign a written informed consent document prior to any study specific procedures, sampling, and analyses
+Provision of informed consent prior to any study specific procedures, sampling and analyses.
+Provision of signed and dated, written informed consent prior to any study specific procedures, sampling and analyses
+Ability to understand and the willingness to sign a written informed consent document prior to any study specific procedures, sampling, and analyses
+Provision of signed and dated written informed consent prior to any study specific procedures, sampling analysis